Skip to content

Clinical trials

Phase 3 Metabolic Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Syndrome Phase: Phase 3 Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20063
20082
20111
20131
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated3
Active, not recruiting1
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi2
Brigham and Women's Hospital1
Johns Hopkins University1
Medstar Health Research Institute1
National Institute on Aging (NIA)1
NewAmsterdam Pharma1
Northeastern Ohio Universities College of Medicine1
Northwestern University1
Prism Health North Texas1
University of Colorado, Denver1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Syndrome12
Diabetes Mellitus, Type 24
Obesity4
Acquired Immunodeficiency Syndrome1
Arteriosclerosis1
Bipolar Disorder1
Body Weight Changes1
Cardiovascular Diseases1
Carotid Artery Diseases1
Carotid Stenosis1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.